Anticoagulant and Antiarrhythmic Management Based on Continuous Rhythm Monitoring

New Onset Atrial Fibrillation Clinical Trial

Official title:
Anticoagulant and Antiarrhythmic Management Based on Continuous Rhythm Monitoring and Cardiac Imaging in Patients at Low Risk for Cardiovascular Events Following Direct Current Cardioversion for New Onset Atrial Fibrillation

Status Recruiting

Clinical Trial Summary

This pilot study aims to assess the feasibility and safety of using an ILR to identify the incidence of recurrent AF after an episode of newly diagnosed AF. The study further aims to assess the risk of AF recurrence in this low risk population based on left atrial and left atrial appendage anatomic and functional indices in addition to the standardized clinical CHA2DS2-Vasc score.

Clinical Trial Description

There is a significant incidence of recurrent AF following initial diagnosis of AF.

Inclusion of left atrial (LA) and left atrial appendage (LAA) abnormalities together with risk prediction of CVA using CHA2DS2-Vasc score will identify patients at low or high risk for adverse cardiovascular events in patients with manifest and silent AF.

Patients requiring cardioversion have higher risk of recurrent AF in follow up. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04038944
Study type	Observational
Source	St. Francis Hospital, New York
Contact	Joseph Levine, MD
Phone	516-742-5700
Email	joseph.levine@chsli.org
Status	Recruiting
Phase
Start date	July 17, 2019
Completion date	September 2023

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04092621` - Rapid Atrial Fibrillation Treatment Strategy	Phase 4
Recruiting	`NCT05169866` - Nifekalant Versus Amiodarone in New-Onset Atrial Fibrillation After Cardiac Surgery	Phase 3
Terminated	`NCT02668432` - Use of Amiodarone in Atrial Fibrillation Associated With Severe Sepsis or Septic Shock	Phase 4
Completed	`NCT03977883` - Management of Paroxystic Atrial Fibrillation in French Intensive Care Units
Completed	`NCT05511649` - New-Onset Atrial Fibrillation Complicating Acute Myocardial Infarction in China
Recruiting	`NCT05229211` - Tracking Atrial Fibrillation After Intensive Care Admission
Recruiting	`NCT05829317` - Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients	Phase 4
Recruiting	`NCT04472299` - Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery	Phase 4